Dr. Chiara Cremolini on the Updated Results of the TRIBE2 Study for Unresectable Colorectal Cancer

June 10, 2019
Chiara Cremolini, MD

Cancer Network spoke with Chiara Cremolini, MD, about the updated results of the phase III randomized strategy study TRIBE2, which looked at the first- and second-line treatment of unresectable metastatic colorectal cancer.

Cancer Network spoke with Chiara Cremolini, MD, of Azienda Ospedaliero-Universitaria Pisana, about the updated results of the phase III randomized strategy study TRIBE2, which looked at the first- and second-line treatment of unresectable metastatic colorectal cancer.

Related Content:

ASCO | Colorectal Cancer